News

Johannes Kohl has been named the 2018 grand prize winner in the annual international competition for The Eppendorf & Science Prize for Neurobiology, for research that makes sense of how a cluster of neurons controls parenting behavior in mice.

An artificial intelligence (AI) approach based on deep learning convolutional neural network (CNN) could identify nuanced mammographic imaging features specific for recalled but benign (false-positive) mammograms and distinguish such mammograms from those identified as malignant or negative.

Mature neurons have been changed directly from one kind to another, challenging prevailing views of cell development.

In the fight against aflatoxin, dairy producers use sequestering agents, such as clay, to reduce transference of the toxin into milk, but clay has additional benefits for overall cow health.

Scientists at McGill have found the answer to a question that perplexed Charles Darwin; if natural selection works at the level of the individual, fighting for survival and reproduction, how can a single colony produce worker ants that are so dramatically different in size – from “minor” workers to large-headed soldiers with huge mandibles – especially if they are sterile?

A way to disrupt the tumor microenvironment of an aggressive form of breast cancer has been identified, showing therapeutic promise.

Scientists have developed a successful method to make truly personalized predictions of future disease outcomes for patients with certain types of chronic blood cancers. The study combined extensive genetic and clinical information to predict the prognosis for patients with myeloproliferative neoplasms.

For centuries, gardeners have attempted to breed blue roses with no success. But now, thanks to modern biotechnology, the elusive blue rose may finally be attainable. Researchers have found a way to express pigment-producing enzymes from bacteria in the petals of a white rose, tinting the flowers blue.

Does fast food contribute to depression? Can a healthy diet combat mental illness?

By determining the molecular signatures of Alzheimer’s, CTE and other conditions, research team to pave way for treatments that target hallmarks of neurodegenerative disease.